Harvard Bioscience (HBIO) Amortization of Goodwill (2025)

Harvard Bioscience (HBIO) reported Amortization of Goodwill of $48.0 million for Q1 2025.

Harvard Bioscience (HBIO) Amortization of Goodwill (2025) Analysis & Trends

Harvard Bioscience (HBIO) has 1 years of Amortization of Goodwill data on file, last reported at $48.0 million in Q1 2025.

  • Amortization of Goodwill for Q1 2025 came in at $48.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $48.0 million (changed N/A YoY), and the FY2025 annual result was $48.0 million, changed N/A from the prior year.
  • Amortization of Goodwill held at $48.0 million in Q1 2025 per HBIO's latest filing.
  • Over five years, Amortization of Goodwill peaked at $48.0 million in Q1 2025 and troughed at $48.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Harvard Bioscience 26.17 Mn 19.07 Mn 12.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 48.00 Mn
Mar 31, 2025 48.00 Mn